SAFETY OF FLEXIBLE BRONCHOSCOPY: PREMEDICATION

Download full text PDF
Issue: 
11
Year: 
2016

M. Shteiner (1,2), MD 1 -Samara City Hospital Four 2 -Samara State Medical University

Premedication is one of the methods to ensure the safety of flexible endoscopy. The traditional approach to premedication provided technical bronchoscopy facilities due to sedation and inhibited secretion, but it ceased to prove its worth when bronchoscopy was commonly performed in patients with severe somatic diseases. In this situation, there was a need for inhaled bronchodilators acting mainly in the tracheobronchial tree and showing a minimized systemic effect (M-anticholinergics and β2-agonists), parenteral glucocorticosteroids, which are characterized by their broncholytic potency in conjunction with certain cardioprotective activity. Parenteral theophylline had limited application in premedication schemes.
Keywords: 
pulmonology
flexible bronchoscopy
premedication

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Zavala D., Godsey K., Bedell G. The response to atropine sulfate given by aerosol and intramuscular routes to patients undergoing fiberoptic bronchoscopy // Chest. – 1981; 796: 512–5.
  2. Lukomskij G.I., Shulutko M.L., Vinner M.G. i dr. Bronhopul'monologija / M.: Meditsina, 1982; 399 s.
  3. Davis G., Brody A., Landis J. Quantization of inflammatory activity in interstitial pneumonitis by bronchofiberscopic pulmonary lavage // Chest. – 1976; 70 (1): 265–6.
  4. Shubik Ju.V. Fibrilljatsija predserdij: kakoj dolzhna byt' tsel' lechenija? // Kardiologija. – 2010; 1: 2–4.
  5. Hassan G., Qurechi W., Khan G. et al. Cardiovascular Consequence of Fiberoptic Bronchoscopy // J. K. Science. – 2005; 7 (1): 1–2.
  6. Nicholson B. Responsible prescribing of orioids for the management of chronic pain // Drugs. – 2003; 63 (1): 17–32.
  7. Pan P., Lee S., Harris L. Chronobiology of subarachnoid fentanyl for labor analgesia // Anesthesiology. – 2005; 103 (3): 454–6.
  8. Glumcher V.S. Anesteziologicheskoe obespechenie patsientov s soputstvujuschej patologiej serdechno-sosudistoj sistemy // Ostrye i neotlozhnye sostojanija v praktike vracha (Ukraina). – 2008; 5/6 (13) (internet-versija): Rezhim dostupa: http://urgent.health-ua.com/articles/?start_pos=10&max_rec=42&cat= intensivterapia&num=
  9. Duncan A., Barr A. Diazepam premedication and awareness during general anaesthesia for bronchoscopy and laryngoscopy // Br. J. Anesthesia. – 1973; 45: 1150–2.
  10. del Cuvillo A., Millol J., Bartra J. et al. Comparative pharmacology of H1-antihistamines // J. Invest. Allergol. Clin. Immunol. – 2006; 16 (1): 3–12.
  11. Calverley P., Scott S. Is airway inflammation in Chronic Obstructive Pulmonary Disease (COPD) a risk factor for cardiovascular events? // J. Chron. Obstruct. Pulm. Dis. – 2006; 3: 233–42.
  12. Kalashnikov N.A. Opyt i osnovnye napravlenija optimizatsii fibrobronhoskopii u patsientov starshe 80 let // Ukraïns'kiï zhurnal maloinvazivnoi ta endoskopichnoï hirurgii. – 2000; 4 (2): 6–8.
  13. Strok A.B., Galeeva Zh.A. Osnovnye aspekty ispol'zovanija ingaljatsionnyh sredstv dostavki lekarstvennyh preparatov v lechenii zabolevanij dyhatel'nyh putej // Lechebnoe delo. – 2011; 2: 10–4.
  14. Barnes P. Distribution of receptor targets in the lung // Proc. Am. Thorac. Soc. – 2004; 4 (1): 345–51.
  15. Avdeev S.N. Antiholinergicheskie preparaty pri obstruktivnyh zabolevanijah legkih. Internet-publikatsija. – 2009; Rezhim dostupa: http:// www.medlinks. ru/article.php?sid=22728
  16. Stanbrook M. Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD // Evid. Based Med. – 2009; 14 (2): 42–3.
  17. McGraw D., Liggett S. Molecular mechanisms of beta2-adrenergic receptor function and regulation // Proc. Amer. Thorac. Soc. – 2005; 2 (4): 292–6.
  18. Wechsler M., Lehman E., Lazarus S. Beta-adrenergic receptor polymorphisms and response to salmeterol // Am. J. Respir. Crit. Care Med. – 2006; 173: 519–26.
  19. Chernehovskaja N.E. Rentgeno-endoskopicheskaja diagnostika zabolevanij organov dyhanija / M.: MEDpress-inform, 2007; 240 s.
  20. Stolz D., Pollak V., Chhajed P. et al. A Randomized, Placebo-Controlled Trial of Bronchodilators for Bronchoscopy in Patients With COPD // Chest. – 2007; 131 (3): 765–72.
  21. Javelov I.S. O bezopasnosti dlitel'no dejstvujuschih β2-agonistov. Vzgljad kardiologa // Pul'monologija. – 2007; 1: 112–6.
  22. Belousov Ju.B., Luk'janov S.V., Duhanin A.S. Sovremennye predstavlenija o farmakodinamike teofillina // Kachestvennaja klinicheskaja praktika. – 2004; 3: 4–9.
  23. Duffy N., Walker P., Diamantea F. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial // Thorax. – 2005; 60: 713–7.
  24. Nakhosteen J. Bronchofiberscopy in Asthmatics: a Method for Minimizing Risk of Complications // Respiration. – 1978; 36: 112–6.
  25. Mikami K., Suzuki M., Kitagawa H. Efficacy of corticosteroidsin the treatment of community-acquired pneumonia requiring hospitalization // Lung. – 2007; 185 (5): 249–55.
  26. Macie C., Wooldrage K., Manfreda J. et al. Inhaled Corticosteroids and Mortality in COPD // Chest. – 2006; 130: 640–6.
  27. Shtejner M.L. Varianty medikamentoznoj podgotovki k bronhoskopii u patsientov s hronicheskoj obstruktivnoj patologiej legkih // Vrach. – 2014; 11: 45–7.